1272 - Transurethral Injection of Botulinum Toxin (Botox) into the Bladder Wall for Urinary Incontinence due to Idiopathic Overactive Bladder

Page last updated: 11 July 2016

Application Detail

Status

Closed

Description of Medical Service

Transurethral injection of Botox into the inner bladder wall, guided by cystoscopy for the treatment of urinary incontinence.

Description of Medical Condition

diopathic overactive bladder with urinary incontinence

Overactive bladder is caused by a dysfunction in the coordinated mechanisms that provide controlled storage and voiding of urine. This can lead to sudden urges to urinate, which may be difficult to suppress, leading to the involuntary loss of urine (incontinence). Bladder overactivity is also associated with increased pressure within the bladder, which can lead to upper urinary tract complications and renal damage. For idiopathic overactive bladder, the cause of bladder dysfunction is unknown.

Reason for Application

-

Medical Service Type

-

Previous Application Number

Not Applicable

Associated Documentation

Application Form

-

PICO Confirmation

13-14 December 2012
Final Protocol (PDF 162 KB)
Final Protocol (Word 341 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 196 KB)
Public Summary Document (Word 83 KB)

Meetings for this Application

PASC

16 - 17 August 2012
13 - 14 December 2012

ESC

-

MSAC

28 November 2013